Welcome to our dedicated page for Stryker news (Ticker: SYK), a resource for investors and traders seeking the latest updates and insights on Stryker stock.
Stryker Corporation (NYSE: SYK) is a global innovator in medical technologies, driving advancements in orthopedics, surgical equipment, and digital healthcare solutions. This dedicated news hub provides investors and healthcare professionals with essential updates on SYK's latest developments, financial performance, and strategic initiatives.
Access authoritative information on earnings announcements, product innovations, regulatory milestones, and acquisition activity. Our curated collection ensures timely access to press releases covering SYK's neurotechnology systems, AI-assisted surgical tools, and minimally invasive treatment solutions that shape modern healthcare.
Key updates include quarterly financial results, FDA clearances for medical devices, partnership announcements, and insights into SYK's expanding digital health ecosystem. Stay informed about developments in robotic-assisted surgery platforms, smart operating room integrations, and global market expansion efforts.
Bookmark this page for streamlined access to verified SYK updates. Check regularly for objective reporting on how Stryker's innovations in joint replacement technologies, emergency care equipment, and healthcare IT solutions continue impacting patient outcomes worldwide.
Stryker announced its intent to complete the acquisition of Wright Medical Group, with approximately 96% of shares validly tendered as of November 10, 2020. The cash tender offer for Wright's shares expired on the same day, and Stryker plans to accept all validly tendered shares on November 11, 2020, following the specified purchase agreement. This strategic acquisition is expected to enhance Stryker's market position and product offerings in the medical technology field.
Stryker (NYSE:SYK) has elected Giovanni Caforio, M.D., Chairman and CEO of Bristol Myers Squibb, to its Board of Directors, effective December 1, 2020. Kevin Lobo, CEO of Stryker, highlighted Dr. Caforio's extensive experience as a physician and business leader, emphasizing his contributions to patient-focused innovations. Dr. Caforio brings significant expertise in biopharmaceuticals, having led Bristol Myers Squibb since 2015, including the notable acquisition of Celgene. Stryker aims to enhance healthcare through innovative medical solutions.
Stryker (NYSE: SYK) has received all regulatory approvals for its cash tender offer for Wright Medical Group N.V. (NASDAQ: WMGI). The U.S. Federal Trade Commission approved the transaction on November 3, 2020, followed by the UK Competition and Markets Authority. To facilitate this acquisition, Stryker agreed to divest its STAR total ankle replacement product and finger joint replacement products. The tender offer is set to expire at 5:00 p.m. ET on November 10, 2020, with completion subject to conditions outlined in the tender offer statement.
Stryker reported a net sales increase of 4.2% to $3.7 billion for Q3 2020, despite COVID-19 disruptions.
Organic net sales rose 3.3%, with adjusted EPS climbing 12% to $2.14. Reported net income grew 33.3% to $621 million. Operating income margin improved to 28%, a 260 bps increase. Stryker refrained from providing Q4 or full-year guidance due to pandemic uncertainties.
Stryker (NYSE: SYK) announced an extension for its cash tender offer for Wright Medical Group N.V. (NASDAQ: WMGI) shares, now set to expire on November 10, 2020. As of October 23, 2020, approximately 12.4% of Wright's shares have been tendered. The completion of the tender offer is contingent upon various conditions outlined in the Schedule TO filed with the SEC. Shareholders who have already tendered do not need to take further action. For more details, shareholders are advised to contact Innisfree M&A Incorporated.
Stryker (NYSE: SYK) announced an extension of its cash tender offer for Wright Medical Group (NASDAQ: WMGI). The new expiration is set for October 28, 2020. As of October 12, 2020, approximately 10.7% of Wright's outstanding shares, or 13,870,057 shares, were tendered. The completion of this offer is subject to conditions outlined in previous filings with the SEC. Shareholders who have tendered do not need to act again due to this extension. Innisfree M&A Incorporated serves as the information agent for the tender offer.
Stryker (NYSE: SYK) has extended the offering period for its cash tender offer for Wright Medical Group N.V. (NASDAQ: WMGI) shares until October 14, 2020. As of September 28, 2020, 13,817,681 Wright Medical shares, about 10.6% of the outstanding shares, had been validly tendered. The tender offer is subject to the conditions in the Schedule TO filed with the SEC. Shareholders who already tendered do not need to act again. Stryker is a leading medical technology company focused on improving healthcare outcomes.
Stryker (NYSE: SYK) announced an extension of its cash tender offer for all outstanding shares of Wright Medical Group N.V. (NASDAQ: WMGI). The offer period is now set to expire on October 14, 2020, unless further extended. As of September 28, 2020, approximately 10.6% of Wright Medical's ordinary shares had been validly tendered. The completion of the tender offer is contingent upon various conditions as outlined in the Schedule TO filed with the SEC. Shareholders do not need to take further action if they have already tendered their shares.
Stryker (NYSE:SYK) will host a conference call on October 29, 2020, at 4:30 p.m. ET to discuss its Q3 2020 operating results and provide an operational update. The final results will be released at 4:05 p.m. ET on the same day. Interested participants can join the call by dialing (877) 702-4565 for domestic calls or (647) 689-5532 for international calls, using conference ID 5297589. A webcast will be available on Stryker's website, which will also host archived recordings of the call from October 29, 2020, 8:00 p.m. ET until November 5, 2020, 11:59 p.m. ET.
Stryker (NYSE:SYK) will host a conference call on October 29, 2020, at 4:30 p.m. ET, to discuss its operating results for the quarter ended September 30, 2020. The final results will be released at 4:05 p.m. on the same day. To join the call, dial (877) 702-4565 domestically or (647) 689-5532 internationally, using conference ID 5297589. A webcast will be available on their website, and the call will be archived for later access until November 5, 2020.
FAQ
What is the current stock price of Stryker (SYK)?
What is the market cap of Stryker (SYK)?
